Bepotastine salicylate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBepotastine salicylate
Drug Alias NameBerionBelion
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/01/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeR06
Related LinksN/A